These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 37249834)

  • 21. Evaluation of cardiac toxicity of systemic treatments in Moroccan patients followed for localized breast cancer: Prospective observational study of 549 cases.
    Haffadi M; Tawfiq N; Dakir M; Boughafour M; Bouchbika Z; Benchakroun N; Jouhadi H; Sahraoui S; Benider A; Krikez I; Benmallek R; Habbal R
    Gulf J Oncolog; 2021 Jan; 1(35):59-65. PubMed ID: 33716214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart failure prevention and monitoring strategies in HER2-positive breast cancer: a narrative review.
    Jafari L; Akhter N
    Breast Cancer Res Treat; 2021 Apr; 186(2):295-303. PubMed ID: 33481134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.
    Gavila J; Seguí MÁ; Calvo L; López T; Alonso JJ; Farto M; Sánchez-de la Rosa R
    Clin Transl Oncol; 2017 Jan; 19(1):91-104. PubMed ID: 27101413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy.
    Han X; Zhou Y; Liu W
    NPJ Precis Oncol; 2017; 1(1):31. PubMed ID: 29872712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
    Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
    BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off.
    Upshaw JN; Ruthazer R; Miller KD; Parsons SK; Erban JK; O'Neill AM; Demissei B; Sledge G; Wagner L; Ky B; Kent DM
    Clin Breast Cancer; 2019 Aug; 19(4):259-267.e1. PubMed ID: 31175052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer: the BACCARAT prospective cohort study.
    Jacob S; Pathak A; Franck D; Latorzeff I; Jimenez G; Fondard O; Lapeyre M; Colombier D; Bruguiere E; Lairez O; Fontenel B; Milliat F; Tamarat R; Broggio D; Derreumaux S; Ducassou M; Ferrières J; Laurier D; Benderitter M; Bernier MO
    Radiat Oncol; 2016 Apr; 11():54. PubMed ID: 27056179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology.
    Porter C; Azam TU; Mohananey D; Kumar R; Chu J; Lenihan D; Dent S; Ganatra S; Beasley GS; Okwuosa T
    JACC CardioOncol; 2022 Sep; 4(3):302-312. PubMed ID: 36213359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
    Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
    Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current perspectives of cardio-oncology: Epidemiology, adverse effects, pre-treatment screening and prevention strategies.
    Bychowski J; Sobiczewski W
    Cancer Med; 2023 Jul; 12(13):14545-14555. PubMed ID: 37102247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac complications of cancer therapies.
    Mauro AG; Hunter K; Salloum FN
    Adv Cancer Res; 2022; 155():167-214. PubMed ID: 35779874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer.
    Yu AF; Mukku RB; Verma S; Liu JE; Oeffinger KC; Steingart RM; Hudis CA; Dang CT
    Breast Cancer Res Treat; 2017 Nov; 166(1):241-247. PubMed ID: 28710537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units].
    Hameau R; Gabrielli L; Garrido M; Guzmán AM; Retamal I; Vacarezza MJ; Greig D; Ocqueteau M; Sánchez C; Pizarro M; Corvalán A; Lavandero S; Castro PF; Martínez G
    Rev Med Chil; 2018 Jan; 146(1):68-77. PubMed ID: 29806680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer.
    Yu AF; Manrique C; Pun S; Liu JE; Mara E; Fleisher M; Patil S; Jones LW; Steingart RM; Hudis CA; Dang CT
    Oncologist; 2016 Apr; 21(4):418-24. PubMed ID: 26984450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical management of drug-induced cardiotoxicity in patients with HER-2+ breast cancer: current recommendations and future outlook.
    Chianca M; L'Abbate S; Fabiani I; Aimo A; Emdin M; Passino C; Fedele A; Cipolla CM; Cardinale DM
    Expert Opin Drug Metab Toxicol; 2023 Feb; 19(2):109-119. PubMed ID: 36989398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular toxicity of biologic agents for cancer therapy.
    Bhave M; Akhter N; Rosen ST
    Oncology (Williston Park); 2014 Jun; 28(6):482-90. PubMed ID: 25134321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precision Cardio-Oncology: a Systems-Based Perspective on Cardiotoxicity of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors.
    Brown SA; Ray JC; Herrmann J
    J Cardiovasc Transl Res; 2020 Jun; 13(3):402-416. PubMed ID: 32253744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of Cardiotoxicities With Traditional and Novel Chemotherapeutic Agents.
    Sharalaya Z; Collier P
    Curr Heart Fail Rep; 2018 Aug; 15(4):260-269. PubMed ID: 29938321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer.
    Mantarro S; Rossi M; Bonifazi M; D'Amico R; Blandizzi C; La Vecchia C; Negri E; Moja L
    Intern Emerg Med; 2016 Feb; 11(1):123-40. PubMed ID: 26712595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiotoxicity of Contemporary Breast Cancer Treatments.
    Lee Chuy K; Yu AF
    Curr Treat Options Oncol; 2019 May; 20(6):51. PubMed ID: 31073788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.